Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents
Gespeichert in:
| Veröffentlicht in: | Journal of antimicrobial chemotherapy 2003-01, Vol.51 (1), p.196-199 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 199 |
|---|---|
| container_issue | 1 |
| container_start_page | 196 |
| container_title | Journal of antimicrobial chemotherapy |
| container_volume | 51 |
| creator | Jones, Mark E. Blosser-Middleton, Renée S. Critchley, Ian A. Karlowsky, James A. Thornsberry, Clyde Sahm, Daniel F. |
| description | |
| doi_str_mv | 10.1093/jac/dkg030 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72885797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72885797</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-c861c20e44dc76b402d6437756bab924a9b79bbad580ac5171c62b23f03ee3d23</originalsourceid><addsrcrecordid>eNpFkc9u1DAQxi0EokvLhQdAPnFAhPpPYifcqlXLIrZCRVSquFiOM9l1m8TBdlr2xjv0TXgQHoInqaus4DSamZ--TzMfQq8oeU9JxY-vtTlubjaEkydoQXNBMkYq-hQt0qTIZF7wA_QihGtCiChE-RwdUJZXvKTlAt2fmGhvbdxh1-JWezfCAP07rPEAd7idvJ7bjbZDiPh0eiT0gD2E0Xodnd_hUcet28AQsHFdByZCg5vJ22GDWfL8--s-FfohaRrXj9rb4AZ8Z-MWu7gFj__8zjptou6TDQwxHKFnre4CvNzXQ3R5dvptucrWXz5-Wp6sM8NLETNTCmoYgTxvjBR1Tlgjci5lIWpdVyzXVS2rutZNURJtCiqpEaxmvCUcgDeMH6I3s-7o3Y8JQlS9DQa6Lt3spqAkK8tCVjKBb2fQeBeCh1aN3vba7xQl6jEClSJQcwQJfr1Xneoemv_o_ucJyGbAhgg__-21v1FCclmo1dV3tV5dfP5K1udqyR8AwqOU0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72885797</pqid></control><display><type>article</type><title>Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Jones, Mark E. ; Blosser-Middleton, Renée S. ; Critchley, Ian A. ; Karlowsky, James A. ; Thornsberry, Clyde ; Sahm, Daniel F.</creator><creatorcontrib>Jones, Mark E. ; Blosser-Middleton, Renée S. ; Critchley, Ian A. ; Karlowsky, James A. ; Thornsberry, Clyde ; Sahm, Daniel F.</creatorcontrib><identifier>ISSN: 0305-7453</identifier><identifier>ISSN: 1460-2091</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkg030</identifier><identifier>PMID: 12493818</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; beta-Lactams ; Drug Resistance, Bacterial - physiology ; Europe - epidemiology ; Haemophilus influenzae - drug effects ; Haemophilus influenzae - isolation & purification ; Humans ; Lactams ; Microbial Sensitivity Tests - statistics & numerical data ; Moraxella (Branhamella) catarrhalis - drug effects ; Moraxella (Branhamella) catarrhalis - isolation & purification ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - epidemiology ; Respiratory Tract Infections - microbiology ; Streptococcus pneumoniae - drug effects ; Streptococcus pneumoniae - isolation & purification</subject><ispartof>Journal of antimicrobial chemotherapy, 2003-01, Vol.51 (1), p.196-199</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-c861c20e44dc76b402d6437756bab924a9b79bbad580ac5171c62b23f03ee3d23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12493818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jones, Mark E.</creatorcontrib><creatorcontrib>Blosser-Middleton, Renée S.</creatorcontrib><creatorcontrib>Critchley, Ian A.</creatorcontrib><creatorcontrib>Karlowsky, James A.</creatorcontrib><creatorcontrib>Thornsberry, Clyde</creatorcontrib><creatorcontrib>Sahm, Daniel F.</creatorcontrib><title>Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J. Antimicrob. Chemother</addtitle><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>beta-Lactams</subject><subject>Drug Resistance, Bacterial - physiology</subject><subject>Europe - epidemiology</subject><subject>Haemophilus influenzae - drug effects</subject><subject>Haemophilus influenzae - isolation & purification</subject><subject>Humans</subject><subject>Lactams</subject><subject>Microbial Sensitivity Tests - statistics & numerical data</subject><subject>Moraxella (Branhamella) catarrhalis - drug effects</subject><subject>Moraxella (Branhamella) catarrhalis - isolation & purification</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - epidemiology</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Streptococcus pneumoniae - drug effects</subject><subject>Streptococcus pneumoniae - isolation & purification</subject><issn>0305-7453</issn><issn>1460-2091</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc9u1DAQxi0EokvLhQdAPnFAhPpPYifcqlXLIrZCRVSquFiOM9l1m8TBdlr2xjv0TXgQHoInqaus4DSamZ--TzMfQq8oeU9JxY-vtTlubjaEkydoQXNBMkYq-hQt0qTIZF7wA_QihGtCiChE-RwdUJZXvKTlAt2fmGhvbdxh1-JWezfCAP07rPEAd7idvJ7bjbZDiPh0eiT0gD2E0Xodnd_hUcet28AQsHFdByZCg5vJ22GDWfL8--s-FfohaRrXj9rb4AZ8Z-MWu7gFj__8zjptou6TDQwxHKFnre4CvNzXQ3R5dvptucrWXz5-Wp6sM8NLETNTCmoYgTxvjBR1Tlgjci5lIWpdVyzXVS2rutZNURJtCiqpEaxmvCUcgDeMH6I3s-7o3Y8JQlS9DQa6Lt3spqAkK8tCVjKBb2fQeBeCh1aN3vba7xQl6jEClSJQcwQJfr1Xneoemv_o_ucJyGbAhgg__-21v1FCclmo1dV3tV5dfP5K1udqyR8AwqOU0A</recordid><startdate>200301</startdate><enddate>200301</enddate><creator>Jones, Mark E.</creator><creator>Blosser-Middleton, Renée S.</creator><creator>Critchley, Ian A.</creator><creator>Karlowsky, James A.</creator><creator>Thornsberry, Clyde</creator><creator>Sahm, Daniel F.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200301</creationdate><title>Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents</title><author>Jones, Mark E. ; Blosser-Middleton, Renée S. ; Critchley, Ian A. ; Karlowsky, James A. ; Thornsberry, Clyde ; Sahm, Daniel F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-c861c20e44dc76b402d6437756bab924a9b79bbad580ac5171c62b23f03ee3d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>beta-Lactams</topic><topic>Drug Resistance, Bacterial - physiology</topic><topic>Europe - epidemiology</topic><topic>Haemophilus influenzae - drug effects</topic><topic>Haemophilus influenzae - isolation & purification</topic><topic>Humans</topic><topic>Lactams</topic><topic>Microbial Sensitivity Tests - statistics & numerical data</topic><topic>Moraxella (Branhamella) catarrhalis - drug effects</topic><topic>Moraxella (Branhamella) catarrhalis - isolation & purification</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - epidemiology</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Streptococcus pneumoniae - drug effects</topic><topic>Streptococcus pneumoniae - isolation & purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Mark E.</creatorcontrib><creatorcontrib>Blosser-Middleton, Renée S.</creatorcontrib><creatorcontrib>Critchley, Ian A.</creatorcontrib><creatorcontrib>Karlowsky, James A.</creatorcontrib><creatorcontrib>Thornsberry, Clyde</creatorcontrib><creatorcontrib>Sahm, Daniel F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Mark E.</au><au>Blosser-Middleton, Renée S.</au><au>Critchley, Ian A.</au><au>Karlowsky, James A.</au><au>Thornsberry, Clyde</au><au>Sahm, Daniel F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J. Antimicrob. Chemother</addtitle><date>2003-01</date><risdate>2003</risdate><volume>51</volume><issue>1</issue><spage>196</spage><epage>199</epage><pages>196-199</pages><issn>0305-7453</issn><issn>1460-2091</issn><eissn>1460-2091</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>12493818</pmid><doi>10.1093/jac/dkg030</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7453 |
| ispartof | Journal of antimicrobial chemotherapy, 2003-01, Vol.51 (1), p.196-199 |
| issn | 0305-7453 1460-2091 1460-2091 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72885797 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
| subjects | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use beta-Lactams Drug Resistance, Bacterial - physiology Europe - epidemiology Haemophilus influenzae - drug effects Haemophilus influenzae - isolation & purification Humans Lactams Microbial Sensitivity Tests - statistics & numerical data Moraxella (Branhamella) catarrhalis - drug effects Moraxella (Branhamella) catarrhalis - isolation & purification Respiratory Tract Infections - drug therapy Respiratory Tract Infections - epidemiology Respiratory Tract Infections - microbiology Streptococcus pneumoniae - drug effects Streptococcus pneumoniae - isolation & purification |
| title | Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T21%3A47%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activity%20of%20faropenem,%20a%20new%20furanem,%20against%20European%20respiratory%20pathogens%20collected%20during%202000%E2%80%932001:%20a%20comparison%20with%20other%20%CE%B2-lactam%20agents&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Jones,%20Mark%20E.&rft.date=2003-01&rft.volume=51&rft.issue=1&rft.spage=196&rft.epage=199&rft.pages=196-199&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dkg030&rft_dat=%3Cproquest_cross%3E72885797%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72885797&rft_id=info:pmid/12493818&rfr_iscdi=true |